SJMClass II
Quantitative Hepatitis B Surface Antigen
21 CFR 866.3177 / Microbiology
Classification record
- Product code
- SJM
- Device name
- Quantitative Hepatitis B Surface Antigen
- FDA definition
- A quantitative hepatitis B virus (HBV) surface antigen (HBsAg) test is an in vitro diagnostic device intended for prescription use for the quantitative determination of HBsAg in human serum, plasma, or other matrices specimens from individuals with HBV infection as an aid in the management of HBV-infected individuals including identifying patients who may benefit from treatment with appropriate antiviral therapies in accordance with the approved therapeutic product labeling.
- Regulation
- 21 CFR 866.3177
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 1
- Ingested recalls
- 0
Clearances, product code SJM
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2026 | 1 |
Applicants with the most clearances
Product code SJM| Applicant | Clearances |
|---|---|
| Roche Diagnostics | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
